Mutual of America Capital Management LLC Lowers Stock Holdings in Bruker Co. (NASDAQ:BRKR)

Mutual of America Capital Management LLC decreased its position in shares of Bruker Co. (NASDAQ:BRKR) by 2.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 58,458 shares of the medical research company’s stock after selling 1,270 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Bruker were worth $3,427,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of BRKR. FMR LLC increased its holdings in Bruker by 21.4% in the 3rd quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock valued at $987,981,000 after acquiring an additional 2,521,904 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its holdings in Bruker by 140.3% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company’s stock valued at $66,930,000 after acquiring an additional 666,617 shares during the last quarter. Point72 DIFC Ltd increased its holdings in Bruker by 4,875.9% in the 3rd quarter. Point72 DIFC Ltd now owns 470,171 shares of the medical research company’s stock valued at $32,470,000 after acquiring an additional 460,722 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Bruker by 1,933.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 410,234 shares of the medical research company’s stock valued at $28,331,000 after acquiring an additional 390,057 shares during the last quarter. Finally, State Street Corp increased its holdings in Bruker by 9.6% in the 3rd quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock valued at $250,501,000 after acquiring an additional 318,808 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

BRKR has been the topic of a number of research reports. Wells Fargo & Company reduced their price target on shares of Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a report on Wednesday, November 6th. TD Cowen reduced their target price on shares of Bruker from $72.00 to $70.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Stifel Nicolaus reduced their target price on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a report on Friday, February 14th. Barclays reduced their target price on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Finally, Guggenheim restated a “buy” rating on shares of Bruker in a report on Monday, February 24th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.50.

Bruker Price Performance

BRKR stock opened at $46.87 on Thursday. Bruker Co. has a 12 month low of $45.29 and a 12 month high of $94.86. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The company has a 50-day moving average price of $55.60 and a 200 day moving average price of $59.37. The stock has a market cap of $7.11 billion, a PE ratio of 61.67, a P/E/G ratio of 2.16 and a beta of 1.16.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities research analysts anticipate that Bruker Co. will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Monday, March 17th will be given a $0.05 dividend. The ex-dividend date is Monday, March 17th. This represents a $0.20 annualized dividend and a yield of 0.43%. Bruker’s dividend payout ratio (DPR) is 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.